Detail

Study ID: COG ACNS1831

Title:

A Phase 3 Randomized Study of Selumetinib versus Carboplatin/Vincristine in Newly Diagnosed or Previously Untreated Neurofibromatosis Type 1 (NF1) associated Low-Grade Glioma (LGG)

Location:
Fargo Region
Principal Investigator:
Samuel Milanovich, MD
Disease:
Brain and Nervous System
Stage:
Phase III
Status:
Active - Open to Accrual